Search - tctmd.com

Displaying 81 - 97 of 97

Sort: Relevancy | Date

News Industry News

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

December 16, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

News Daily News

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

June 28, 2013

News Daily News

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

June 28, 2013

News Industry News

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

May 23, 2013

News Daily News

Meta-analysis: Renal Denervation Effective Regardless of Catheter Type

L.A. McKeown

May 17, 2013

News Daily News

Meta Análisis: La Denervación Renal es Efectiva con independencia del Tipo de Catéter

L.A. McKeown

May 17, 2013

News Daily News

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

April 26, 2013

News Daily News

Directrices de la ESC sobre el Uso Apropiado de la Denervación Renal basada en Catéter

April 26, 2013

News Daily News

Renal Denervation Appears Safe for Patients with Kidney Dysfunction

January 09, 2013

News Daily News

La Denervación Renal parece Segura en Pacientes con Disfunción Renal

January 09, 2013

News Daily News

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

L.A. McKeown

December 02, 2012

News Daily News

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

L.A. McKeown

December 02, 2012

News Conference News TCT 2012

More Data Needed on Renal Denervation

October 25, 2012

News Industry News

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

November 04, 2011

News Industry News

Medtronic Starts Landmark Study of Hypertension Treatment

October 26, 2011

News Industry News

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

July 11, 2011

Advertisement

Medtronic Randomizes First Patients in SYMPLICITY HTN-4, the First U.S. Renal Denervation Clinical Study for Patients with Moderate Uncontrolled Hypertension

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Renal Denervation Lowers Ambulatory BP Measurements in Resistant Hypertension

Denervación renal disminuye los índices de PA ambulatoria en la hipertensión resistente

Medtronic Completes Enrollment in Landmark U.S. Study of Symplicity(TM) Renal Denervation System for Treatment-Resistant Hypertension

Meta-analysis: Renal Denervation Effective Regardless of Catheter Type

Meta Análisis: La Denervación Renal es Efectiva con independencia del Tipo de Catéter

ESC Provides Guidance on Appropriate Use of Catheter-Based Renal Denervation

Directrices de la ESC sobre el Uso Apropiado de la Denervación Renal basada en Catéter

Renal Denervation Appears Safe for Patients with Kidney Dysfunction

La Denervación Renal parece Segura en Pacientes con Disfunción Renal

Un Modelo Confirma la Rentabilidad de la Denervación Renal en Varones y Mujeres

Model Shows Cost-Effectiveness of Renal Denervation in Men, Women

More Data Needed on Renal Denervation

Medtronic’s Unmatched Portfolio of Cardiovascular Devices Features Prominently on Program for TCT 2011

Medtronic Starts Landmark Study of Hypertension Treatment

Medtronic Gets Go-Ahead from FDA for Study of Novel Treatment for High Blood Pressure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content